{
    "2020-11-09": [
        [
            {
                "time": "2020-11-09",
                "original_text": "【浙商医药|点评】康龙化成：股权激励常态化，CDMO放量在即，有望超预期",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "股权激励",
                        "CDMO",
                        "放量",
                        "超预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "每日全球并购：康龙化成拟9亿收购美国实验室服务公司，宁德时代领投自动驾驶公司嬴彻科技1.2亿美元融资",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "并购",
                        "美国实验室服务公司",
                        "宁德时代",
                        "嬴彻科技"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "自动驾驶"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "西南证券：双循环背景下 创新升级+进口替代引领医药大时代",
                "features": {
                    "keywords": [
                        "西南证券",
                        "双循环",
                        "创新升级",
                        "进口替代",
                        "医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "【异动股】康龙化成(03759-HK)涨3.01%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "异动股",
                        "涨3.01%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "安信国际 | 医药行业动态分析报告：CRO头部企业Q3业绩保持高增长",
                "features": {
                    "keywords": [
                        "安信国际",
                        "医药行业",
                        "CRO",
                        "Q3业绩",
                        "高增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "康龙化成拟收购于美国的实验室服务公司100%股权",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "收购",
                        "美国实验室服务公司",
                        "100%股权"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "康龙化成(03759.HK)拟收购一家美国实验室服务公司100%股权 总价不超1.375亿美元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "收购",
                        "美国实验室服务公司",
                        "100%股权",
                        "1.375亿美元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}